TABLE 1.
Description of patients with scrub typhus meeting the scrub typhus infection criteria
| CRF no.d | Days of fever | Sexa | Age (yr) | Admission InBios IgM OD | Admission IgM IFA | Convalescent IgM IFA | Admission IgM IFA ≥12,800 | In vitro isolation positive | PCR positive | IgM IFA ≥4-fold increase |
|---|---|---|---|---|---|---|---|---|---|---|
| 4 | 5 | M | 48 | 4.54 | ≥25,600 | ≥25,600 | X | |||
| 6 | 10 | M | 44 | 4.82 | ≥25,600 | ≥25,600 | X | |||
| 8 | F | 44 | 4.39 | ≥25,600 | ≥25,600 | X | ||||
| 22 | 10 | F | 35 | 4.16 | 12,800 | NS | X | X | ||
| 27 | 8 | F | 40 | 4.18 | ≥25,600 | ≥25,600 | X | X | X | |
| 40 | 8 | F | 81 | 0.06 | 50 | 200 | X | |||
| 45 | 3 | M | 84 | 0.06 | 50 | 100 | X | |||
| 57 | 3 | M | 71 | 0.06 | ≥25,600 | 50 | X | X | ||
| 58 | 5 | F | 34 | 3.83 | ≥25,600 | 1,600 | X | X | X | |
| 60 | 7 | F | 38 | 1.10 | ≥25,600 | ≥25,600 | X | X | ||
| 64 | 11 | F | 54 | 4.28 | 12,800 | NSb | X | |||
| 67 | 5 | M | 45 | 0.10 | 100 | 400 | X | |||
| 75 | 4 | M | 46 | 0.10 | 50 | 50 | X | |||
| 76 | 7 | M | 39 | 4.70 | 12,800 | NS | X | |||
| 79 | 8 | M | 31 | 4.45 | ≥25,600 | ≥25,600 | X | X | X | |
| 93 | 7 | F | 43 | 4.73 | ≥25,600 | ≥25,600 | X | X | ||
| 97 | 7 | M | 15 | 4.44 | 100 | ≥25,600 | X | X | ||
| 101 | 4 | M | NAc | 0.62 | 400 | 12,800 | X | |||
| 103 | 5 | M | 44 | 4.14 | ≥25,600 | ≥25,600 | X | X | ||
| 109 | 4 | M | 42 | 0.15 | 100 | 400 | X | |||
| 113 | 4 | M | 32 | 0.12 | 50 | 200 | X | |||
| 116 | 10 | M | 20 | 4.44 | ≥25,600 | ≥25,600 | X | X | ||
| 117 | 10 | M | 18 | 5.17 | ≥25,600 | ≥25,600 | X | |||
| 122 | 5 | M | 44 | 4.59 | 12,800 | NS | X | X | ||
| 123 | 5 | M | 44 | 0.17 | 50 | 400 | X | |||
| 124 | 2 | M | 56 | 0.14 | 50 | 400 | X | |||
| 125 | 3 | M | 49 | 0.09 | 50 | 200 | X | |||
| 127 | 7 | M | 36 | 0.78 | 400 | 1,600 | X | X | ||
| 129 | 7 | F | 55 | 0.25 | 50 | 200 | X | |||
| 130 | 4 | M | 29 | 0.30 | 200 | 800 | X | |||
| 132 | 1 | M | 52 | 0.28 | 50 | 800 | X | |||
| 136 | 5 | M | 29 | 0.52 | 200 | ≥25,600 | X | X | X | |
| 145 | 2 | M | 41 | 0.15 | 50 | 800 | X | |||
| 146 | 6 | M | 40 | 0.09 | 50 | 1,600 | X | |||
| 147 | 6 | M | 38 | 0.11 | 100 | 400 | X | |||
| 148 | 8 | M | 49 | 3.04 | 3,200 | ≥25,600 | X | X | ||
| 158 | 5 | F | 57 | 3.75 | ≥25,600 | ≥25,600 | X | X | X | |
| 162 | 7 | M | 32 | 0.96 | 800 | ≥25,600 | X | |||
| 167 | 2 | M | 58 | 0.16 | 50 | 200 | X | |||
| 168 | 6 | M | 51 | 0.09 | 50 | 800 | X | |||
| 170 | 7 | F | 58 | 4.49 | 12,800 | 3,200 | X | X | ||
| 171 | 4 | F | 41 | 4.77 | 6,400 | ≥25,600 | X | X | ||
| 172 | 10 | F | 26 | 4.48 | ≥25,600 | ≥25,600 | X | X | ||
| Total | Median, 5.5 | M, 69.8%; F, 30.2% | Median, 43.5 | 19 | 7 | 19 | 21 |
M, male; F, female.
NS, no serum.
NA, not available.
CRF no., Chiangrai fever study number.